How is HGH dosed in IU, and how many syringe units is that?
Draw to
unitsmL
0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe
IU is how the drug is measured; units are the marks on the syringe. The draw is the dose in IU divided by the IU in each mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.
Save to Milligram
Open in Milligram shows once the calculator has a result.
Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.
Open in Milligram is off while the draw is under one unit. Check the dose and its unit.
Open in Milligram adds Human growth hormone (somatropin) and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.
The European Omnitrope text gives adults with adult-onset growth hormone deficiency 0.15 to 0.3 mg a day to start, says the maintenance dose rarely exceeds 1.0 mg a day, and gives a 5 mg cartridge as 15 IU.1
The guide's example
2 IU of Somatropin (HGH) from a 10 IU vial mixed with 2 mL is 40 units on a U-100 syringe. The 40 is the syringe's mark, not IU.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Vial | 1 mL of water | 2 mL of water |
|---|---|---|
| 10 IU | 10 IU/mL: 2 IU is 20 units, 3 IU is 30 units, 4 IU is 40 units, 5 IU is 50 units | 5 IU/mL: 2 IU is 40 units, 3 IU is 60 units, 4 IU is 80 units, 5 IU is 100 units |
| 36 IU | 36 IU/mL: 2 IU is 5.6 units, 3 IU is 8.3 units, 4 IU is 11.1 units, 5 IU is 13.9 units | 18 IU/mL: 2 IU is 11.1 units, 3 IU is 16.7 units, 4 IU is 22.2 units, 5 IU is 27.8 units |
Most often logged by Milligram users: 2 IU, 26% logged.13
Vial strengths, water and syringe units
In IU, the de Boer trial of 46 men with growth hormone deficiency gave placebo (n = 13) or 1 (n = 11), 2 (n = 10) or 3 (n = 12) IU/m2.day, and the Ehrnborg trial of thirty healthy volunteers gave 0.1 IU/kg/day or 0.2 IU/kg/day.23 The Humatrope label lists cartridges of 6 mg (18 IU), 12 mg (36 IU) and 24 mg (72 IU).4 The Humatrope label co-packages each cartridge with a diluent syringe of about 3 mL, so the 36 IU rows above are arithmetic, not a label mix.4 The European Omnitrope text gives a 5 mg cartridge as 15 IU and the Humatrope label gives its 12 mg cartridge as 36 IU, while the Humatrope pharmacokinetics line gives a single 0.1 mg/kg dose in 8 healthy subjects as 0.27 IU/kg, so these sources give no single IU-to-mg rule.14
From a 10 IU vial mixed with 2 mL, a 2 IU dose (logged by 26% of the people who logged human growth hormone in Milligram) is 40 units on a U-100 syringe, which holds 100 units per mL.135
2 IU of Somatropin (HGH) from a 10 IU vial mixed with 2 mL is 40 units on a U-100 syringe. The 40 is the syringe's mark, not IU.
26% logged13
Which water the labels name
The US Omnitrope label co-packages its 5.8 mg powder vial with a 1.14 mL vial of bacteriostatic water for injection with 1.5% benzyl alcohol, giving 5 mg/mL after reconstitution.6 The Zomacton label gives 1 mL to 5 mL of bacteriostatic sodium chloride for its 5 mg vial and the 1 mL syringe of bacteriostatic water for its 10 mg vial.7
Doses on labels, in trials and in Milligram logs
For adults with growth hormone deficiency, the Genotropin label gives a weight-based start of not more than 0.04 mg/kg/week, which may be increased as tolerated to not more than 0.08 mg/kg/week at 4 to 8 week intervals, beside a non-weight-based start of approximately 0.2 mg/day (range, 0.15 to 0.30 mg/day).8 Label and trial doses come in mg, mg per kilogram, U per kilogram and IU per square metre, so they are listed side by side rather than converted.
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| de Boer, 19952 | Placebo (n = 13) or 1 (n = 11), 2 (n = 10) or 3 (n = 12) IU/m2.day, started at one third of the dose and raised by another third until the maintenance dose | 46 GHD men | 1-yr |
| Salomon, 19899 | 0.07 U per kilogram of body weight, given subcutaneously at bedtime, or placebo | 24 adults with growth hormone deficiency | six months |
| Ehrnborg, 20053 | Placebo, 0.1 IU/kg/day [0.033 mg/kg/day] or 0.2 IU/kg/day [0.067 mg/kg/day], n = 10 each | Thirty healthy, physically active volunteers (15 men and 15 women) | 1 month |
| Meinhardt, 201010 | Placebo or growth hormone 2 mg/d subcutaneously; men also had testosterone 250 mg/wk intramuscularly or combined arms | 96 recreationally trained athletes (63 men and 33 women) | 8 weeks, then a 6-week washout |
Of the people who logged human growth hormone in Milligram, 99% set up IU, and 26% logged 2 IU, 21% logged 4 IU, 18% logged 3 IU and 8% logged 5 IU.13
Storage before and after mixing
After mixing, the Zomacton label gives up to 14 days refrigerated at 36° to 46°F (2° to 8°C) for a 5 mg vial mixed with its co-packaged bacteriostatic sodium chloride, and up to 28 days for a 10 mg vial mixed with its co-packaged bacteriostatic water, neither frozen.7 The US Omnitrope label says the contents of a mixed vial must be used within 21 days, with the vial stored after the first injection in its original carton in a refrigerator at 2° to 8°C (36° to 46°F).6 Before mixing, the Zomacton label stores vials refrigerated in the carton, while the Serostim label stores cartons at 15°C to 30°C.711
Frequently asked questions
Does growth hormone raise strength in healthy people?
A 2017 meta-analysis by Hermansen and colleagues of 11 placebo-controlled studies with 254 healthy young subjects found growth hormone changed body composition but did not increase muscle strength or aerobic exercise capacity, while it raised anaerobic exercise capacity in the only study that measured it.12
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- European Medicines Agency. Omnitrope (somatropin) EPAR product information, summary of product characteristics. undated. ema.europa.eu
- J Clin Endocrinol Metab, via PubMed. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis (abstract). 1995. pubmed.ncbi.nlm.nih.gov
- Clin Endocrinol, via PubMed. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults (abstract). 2005. pubmed.ncbi.nlm.nih.gov
- Eli Lilly and Company (via DailyMed, US FDA label). HUMATROPE (somatropin) kit, prescribing information. 2026. dailymed.nlm.nih.gov
- Eli Lilly and Company (via DailyMed, US FDA label). Humulin R U-100 (insulin human) prescribing information, used only for the U-100 definition. 2026. dailymed.nlm.nih.gov
- Sandoz (via DailyMed, US FDA label). OMNITROPE (somatropin) injection and for injection, prescribing information. 2026. dailymed.nlm.nih.gov
- Ferring Pharmaceuticals (via DailyMed, US FDA label). ZOMACTON (somatropin) kit, prescribing information. 2026. dailymed.nlm.nih.gov
- Pfizer (via DailyMed, US FDA label). GENOTROPIN (somatropin) for injection, prescribing information. 2026. dailymed.nlm.nih.gov
- N Engl J Med, via PubMed. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency (abstract). 1989. pubmed.ncbi.nlm.nih.gov
- Ann Intern Med, via PubMed. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial (abstract). 2010. pubmed.ncbi.nlm.nih.gov
- EMD Serono (via DailyMed, US FDA label). SEROSTIM (somatropin) kit, prescribing information. 2026. dailymed.nlm.nih.gov
- Growth Horm IGF Res, via PubMed. Impact of GH administration on athletic performance in healthy young adults: a systematic review and meta-analysis (abstract). 2017. pubmed.ncbi.nlm.nih.gov
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted